학술논문
Nivolumab Rechallenge After Immune-related Adverse Events in Patients With Unresectable Advanced or Recurrent Esophageal Cancer
Document Type
Article
Author
Source
In: In Vivo . (In Vivo, March 2024, 38(2):794-799)
Subject
Language
English
ISSN
17917549
0258851X
0258851X